2022年の業績
-
Herik Rodrigo AG, Tomonobu N, Yoneda H, Kinoshita R, Mitsui Y, Sadahira T, Terawaki SI, Gohara Y, Gede Yoni Komalasari NL, Jiang F, Murata H, Yamamoto KI, Futami J, Yamauchi A, Kuribayashi F, Inoue Y, Kondo E, Toyooka S, Nishibori M, Watanabe M, Nasu Y, Sakaguchi M. : Toll-like receptor 4 promotes bladder cancer progression upon S100A8/A9 binding, which requires TIRAP-mediated TPL2 activation.
Biochem Biophys Res Commun. 2022 Dec 17;634:83-91. doi:10.1016/j.bbrc.2022.09.116. Epub 2022 Oct 6. -
Tomonobu N, Kinoshita R, Wake H, Inoue Y, Ruma I-M W, Suzawa K, Gohara Y, Komalasari NLGY, Jiang F, Murata H, Yamamoto K, Sumardika IW, Chen Y, Futami J, Yamauchi A, Kuribayashi F, Kondo E, Toyooka S, Nishibori M, Sakaguchi M.: Histidine-rich Glycoprotein suppresses the S100A8/A9-mediated organotropic metastasis of melanoma cells.
Int J Mol Sci. 2022 Sep 7;23(18):10300. doi: 10.3390/ijms231810300. -
Fukushima H, Kato T, Furusawa A, Okada R, Wakiyama H, Furumoto H, Okuyama S, Kondo E, Choyke PL, Kobayashi H.: Intercellular adhesion molecule-1-targeted near-infrared photoimmunotherapy of triple-negative breast cancer.
Cancer Sci. 2022 Sep;113(9):3180-3192. doi: 10.1111/cas.15466. -
Yokoyama Y, Iioka H, Horii A, Kondo E. Crumbs3 is expressed in oral squamous cell carcinomas and promotes cell migration and proliferation by affecting RhoA activity.
Oncol Lett. 2022 Jun;23(6):173. doi: 10.3892/ol.2022.13293.
